ENDRA Life Sciences Announces Participation in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021
ENDRA Life Sciences Inc. (NASDAQ:NDRA) will participate in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ENDRA Life Sciences Inc. (NASDAQ:NDRA) will participate in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021. This event includes 1-on-1 virtual investor meetings, allowing investors to connect with the management team. ENDRA is a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a technology that visualizes tissue at a fraction of MRI costs. TAEUS® targets chronic liver conditions like Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), affecting over one billion people globally.
Positive
- Participation in A.G.P.'s Virtual MedTech Summer Conference may enhance investor relations.
- TAEUS® technology offers a cost-effective solution for visualizing tissue, potentially increasing market adoption.
Negative
- None.
Details
News Market Reaction – NDRA
The recorded move for NDRA in the trading session of this news was +4.60%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ANN ARBOR, MI / ACCESSWIRE / July 20, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in A.G.P.'s Virtual MedTech Summer Conference on Thursday, July 29, 2021.
The event will consist of 1-on-1 virtual investor meetings. Investors participating in the virtual conference who are interested in meeting with members of ENDRA's management team should contact their A.G.P. representative.
About ENDRA Life Sciences Inc.
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with 400,000 cart-based ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.
Company Contact:
Irina Pestrikova
Senior Director, Finance
investors@endrainc.com
www.endrainc.com
Investor Relations Contact:
Yvonne Briggs
LHA Investor Relations
(310) 691-7100
YBriggs@lhai.com
SOURCE: ENDRA Life Sciences Inc.
View source version on accesswire.com:
https://www.accesswire.com/656074/ENDRA-Life-Sciences-Announces-Participation-in-AGPsVirtual-MedTech-Summer-Conference-on-July-29-2021
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.